Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$1.65 - $3.13 $67,650 - $128,330
-41,000 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$2.1 - $3.54 $86,100 - $145,140
41,000 New
41,000 $22,000
Q4 2021

Feb 10, 2022

SELL
$3.04 - $6.01 $94,240 - $186,310
-31,000 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$5.9 - $7.44 $123,900 - $156,240
21,000 Added 210.0%
31,000 $34,000
Q2 2021

Aug 06, 2021

SELL
$5.78 - $9.6 $43,350 - $72,000
-7,500 Reduced 42.86%
10,000 $5,000
Q1 2021

May 05, 2021

BUY
$5.67 - $12.54 $99,225 - $219,449
17,500 New
17,500 $22,000

Others Institutions Holding NHWK

About NightHawk Biosciences, Inc.


  • Ticker NHWK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,661,500
  • Market Cap $4.11M
  • Description
  • NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...
More about NHWK
Track This Portfolio

Track Magnus Financial Group LLC Portfolio

Follow Magnus Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnus Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnus Financial Group LLC with notifications on news.